vTv Therapeutics VTVT
NASDAQ VTVT
$31.37 +0.53 (+1.72%)
As of: Oct 1, 2026 · 11:27 AM EDT

vTv Therapeutics (VTVT) Capital Expenditures (2014 - 2017)

Updated

vTv Therapeutics (VTVT) recorded Capital Expenditures of $21,000 in FY2022.

Analysis

vTv Therapeutics (VTVT) Capital Expenditures (2014 - 2017) Analysis & Trends

Starting with FY2013, vTv Therapeutics' Capital Expenditures history includes 8 years.

  • Annual Capital Expenditures has a five-year compound annual growth rate of -18.1% (FY2017 to FY2022).
  • The FY2022 figure is the highest annual Capital Expenditures since FY2019.
  • Per Business Quant data, VTVT's Capital Expenditures was $70,000 in FY2019 and $5,000 in FY2018 (-91.2%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.32 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 322.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -763.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 140.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 112.20 Mn
10 vTv Therapeutics 382.70 Mn 382.70 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 18,000.00
Mar 31, 2017 39,000.00
Dec 31, 2015 62,000.00
Sep 30, 2015 9,000.00
Jun 30, 2015 29,000.00
Mar 31, 2015 4,000.00
Dec 31, 2014 -2,000.00
Sep 30, 2014 9,000.00
API Access

vTv Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=VTVT&period=max&api_key=YOUR_API_KEY